Julianne Imperato-McGinley, MD CTSC Principal Investigator and Program Director Associate Dean, translational Research and Education
Weill Cornell was established in 2007 with a Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) - a $61.9 million grant, the largest federal grant ever made to Weill Cornell Medicine, was renewed again in 2022 for another five years to support our multi-institutional efforts, which has funded innovative interdisciplinary projects, education, training programs, and local community health efforts.
As the CTSC Program Director I have worked to establish relationships with our world-renowned institutional partners: Memorial Sloan-Kettering Cancer Center, the Hospital for Special Surgery, NewYork-Presbyterian Hospital, Hunter College and, Cornell University. Through these efforts Hunter College investigators now work out of labs in Weill Cornell Medicine’s Belfer Research Building, where the public institution purchased space, and next year, the Hunter College School of Nursing will relocate to York Avenue to be closer to the CTSC’s institutional partners.
The CTSC is one of more than 60 federally supported programs nationwide that similarly prioritize collaboration, mentorship and community participation. Since it was founded a decade ago, Weill Cornell Medicine’s CTSC has focused on advancing translational science discoveries across a broad spectrum of clinical disciplines and diseases. The CTSC’s achievements are exemplified in its educational and community-based efforts and has emerged as a premier hub for scientific discovery at Weill Cornell and a full-service home for translational research. We hope you will visit our site frequently as it will continue to grow as we continue to identify the needs of the investigators, trainees and community members while implementing new programs that focus on creativity and entrepreneurship.